Description: LabGenomics Co., Ltd., a healthcare company, develops molecular diagnostics products and services in Korea. It offers DNA chips, PCR kits, and POCT; MomGuard, cancer panel, predisposition panel, and PGS; genome sequencing, exome and targeted sequencing, RNA sequencing, epigenome and metagenome, and moleculo services; and esoteric tests, such as cancer genetics, genetic disorders, and prenatal screening. The company's medical devices include STDetect chip kits that enable detection and identification of the microbial pathogens of the sexually transmitted diseases; HPView Chip, which detects and identifies human papilloma virus; LabGun PCR kits for detection and identification of infectious diseases; LabGscan PCR kits for detection and identification of human genetic diseases; MyPCR device; MyGelDoc, which is designed to use personally for documenting the gel electrophoresis images; and LabGenius, which is an automatic and portable in vitro diagnostic medical device. The company was founded in 2002 and is based in Seongnam, South Korea. LabGenomics Co., Ltd. is a subsidiary of VO Industrial Co., Ltd.
Home Page: www.labgenomics.co.kr
Korea Bio Park Building
Seongnam,
463-400
South Korea
Phone:
82 3 1628 0702
Officers
Name | Title |
---|---|
Mr. Sung Hyun Chin | Chief Exec. Officer |
Exchange: KQ
Country: KR
Currency: Korean Won (₩)
Forward PE: | 0 |
---|---|
Trailing PE: | 0 |
Price-to-Book MRQ: | 0 |
Price-to-Sales TTM: | 2.0187 |
IPO Date: | |
Fiscal Year End: | December |
Full Time Employees: | 233 |